| Strength: | |
|---|---|
| Quantity: | |
Brief Introduction:
National Medical Insurance, Category B.
Launched in 2005.
National standard bulk supplier of rHuIL-11.
Participated in the development and collaborative calibration of rHuIL-11 national reference standards.
Indications:
Severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia.
Academic progress
Guideline Express: Expert consensus for diagnosis and treatment of thrombocytopenia in adult critical illness in China
2020-03-11
Guideline Express: Chinese expert consensus on the diagnosis and treatment of chemotherapy-induced thrombocytopenia with acute leukemia
2020-03-10
Research Progress: Efficacy and safety of recombinant human interleukin-11 in the treatment of acute leukemia patients with chemotherapy-induced thrombocytopenia
2020-03-10
Guideline Express: Consensus on clinical diagnosis, treatment and prevention management of chemother induced thrombocytopenia in China (2018)
2020-03-10
Guideline Express: Chinese expert consensus on recombinant human interleukin-11 in clinical treatment of thrombocytopenia
2020-03-09
Brief Introduction:
National Medical Insurance, Category B.
Launched in 2005.
National standard bulk supplier of rHuIL-11.
Participated in the development and collaborative calibration of rHuIL-11 national reference standards.
Indications:
Severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia.
Academic progress
Guideline Express: Expert consensus for diagnosis and treatment of thrombocytopenia in adult critical illness in China
2020-03-11
Guideline Express: Chinese expert consensus on the diagnosis and treatment of chemotherapy-induced thrombocytopenia with acute leukemia
2020-03-10
Research Progress: Efficacy and safety of recombinant human interleukin-11 in the treatment of acute leukemia patients with chemotherapy-induced thrombocytopenia
2020-03-10
Guideline Express: Consensus on clinical diagnosis, treatment and prevention management of chemother induced thrombocytopenia in China (2018)
2020-03-10
Guideline Express: Chinese expert consensus on recombinant human interleukin-11 in clinical treatment of thrombocytopenia
2020-03-09
